Advances in the Management of Gastrointestinal and Liver Diseases
A special issue of Gastroenterology Insights (ISSN 2036-7422). This special issue belongs to the section "Gastrointestinal Disease".
Deadline for manuscript submissions: 31 May 2026 | Viewed by 48
Special Issue Editor
Interests: gastroenterology; cholangioscopy; esophagogastric junction; biliary stones
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The Special Issue entitled "Advances in the Management of Gastrointestinal and Liver Diseases" highlights recent breakthroughs in the understanding and treatment of prevalent gastrointestinal and hepatic disorders, addressing critical challenges related to disease pathogenesis, early detection, and therapeutic innovation.
Recently, notable pharmacological progress has been made regarding metabolic-associated liver disease (MASH), hepatitis C, and the antifibrotic potential of salvianolic acid B in liver fibrosis. Significant advancements have also been achieved in the treatment of inflammatory bowel disease through the development of monoclonal antibodies such as interleukin-23 and Janus kinase (Jak) inhibitors. Additional areas of focus include irritable bowel disease, eosinophilic esophagitis, reflux, Helicobacter pylori, and peptic ulcer disease. Moreover, noteworthy advancements have been made in screening for non-alcoholic fatty liver disease (NAFLD), understanding the pathogenesis of hepatocellular carcinoma (HCC), and developing immune checkpoint blockade strategies for gastrointestinal malignancies. Furthermore, extensive progress in understanding the pathophysiology of these diseases has resulted in enhanced detection methods, risk assessment scores, and screening modalities.
This Special Issue aims to bridge the translational gaps between laboratory findings and clinical practice, emphasizing the importance of precision medicine, early diagnosis, and evidence-based strategies for the management of gastrointestinal and liver diseases. This Special Issue welcomes researchers, clinicians, and policymakers within the fields of gastroenterology, hepatology, oncology, and public health, with the aim of fostering collaborations to address unmet needs in chronic liver disease, metabolic liver disorders, gastrointestinal disorders, and gastrointestinal cancers.
Dr. Micheal Tadros
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Gastroenterology Insights is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nonalcoholic fatty liver disease (NAFLD)
- hepatocellular carcinoma (HCC)
- intrahepatic cholangiocarcinoma (ICC)
- liver fibrosis
- immune checkpoint blockade
- spectral detector CT
- hepatogenic origin
- gastrointestinal malignancies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
